Follow
Steven W Cotten PhD
Title
Cited by
Cited by
Year
Lacosamide isothiocyanate-based agents: novel agents to target and identify lacosamide receptors
KD Park, P Morieux, C Salomé, SW Cotten, O Reamtong, C Eyers, ...
Journal of medicinal chemistry 52 (21), 6897-6911, 2009
622009
Modulation of nucleobindin-1 and nucleobindin-2 by caspases
CA Valencia, SW Cotten, J Duan, R Liu
FEBS letters 582 (2), 286-290, 2008
552008
Drug testing in the neonate
SW Cotten
Clinics in laboratory medicine 32 (3), 449-466, 2012
532012
Unexpected interference of baby wash products with a cannabinoid (THC) immunoassay
SW Cotten, DL Duncan, EA Burch, CJ Seashore, CA Hammett-Stabler
Clinical biochemistry 45 (9), 605-609, 2012
492012
Selection of proteins with desired properties from natural proteome libraries using mRNA display
SW Cotten, J Zou, CA Valencia, R Liu
nature protocols 6 (8), 1163-1182, 2011
352011
Dystrophin-deficient dogs with reduced myostatin have unequal muscle growth and greater joint contractures
JN Kornegay, DJ Bogan, JR Bogan, JL Dow, J Wang, Z Fan, N Liu, ...
Skeletal muscle 6, 1-17, 2016
342016
Reference intervals and diagnostic ranges for serum free κ and free λ immunoglobulin light chains vary by instrument platform: implications for classification of patient …
SW Cotten, Z Shajani-Yi, MA Cervinski, T Voorhees, SA Tuchman, ...
Clinical biochemistry 58, 100-107, 2018
322018
Ca2+/Calmodulin-binding proteins from the C. elegans proteome
X Shen, CA Valencia, W Gao, SW Cotten, B Dong, B Huang, R Liu
Cell calcium 43 (5), 444-456, 2008
312008
mRNA‐Display‐Based Selections for Proteins with Desired Functions: A Protease‐Substrate Case Study
CA Valencia, SW Cotten, B Dong, R Liu
Biotechnology progress 24 (3), 561-569, 2008
302008
Cleavage of BNIP-2 and BNIP-XL by caspases
CA Valencia, SW Cotten, R Liu
Biochemical and biophysical research communications 364 (3), 495-501, 2007
302007
Method performance and clinical workflow outcomes associated with meconium and umbilical cord toxicology testing
RM Labardee, JR Swartzwelder, KE Gebhardt, JA Pardi, AC Dawsey, ...
Clinical Biochemistry 50 (18), 1093-1097, 2017
242017
Genetic myostatin decrease in the golden retriever muscular dystrophy model does not significantly affect the ubiquitin proteasome system despite enhancing the severity of disease
SW Cotten, JN Kornegay, DJ Bogan, KM Wadosky, C Patterson, MS Willis
American journal of translational research 6 (1), 43, 2014
222014
The new collaborative path in medical device development: The medical device innovation consortium
T Kampfrath, SW Cotten
Clinical Biochemistry 46 (15), 1320-1322, 2013
122013
mRNA display-based selections using synthetic peptide and natural protein libraries
SW Cotten, J Zou, R Wang, B Huang, R Liu
Ribosome Display and Related Technologies: Methods and Protocols, 287-297, 2012
122012
Cyclodextrin removal of lipemic interference: an attractive alternative to ultracentrifugation for satellite laboratories
CM Roberts, SW Cotten
Archives of Pathology and Laboratory Medicine 137 (8), 1027-1028, 2013
112013
Evaluation of digital images for identification and characterization of monoclonal immunoglobulins by immunofixation
LM Bender, SW Cotten, Y Fedoriw, MS Willis, CR McCudden
Clinical biochemistry 46 (3), 255-258, 2013
112013
Kids in America: newborn screening for cystic fibrosis
LM Bender, SW Cotten, MS Willis
Laboratory Medicine 42 (10), 595-601, 2011
112011
An introduction to drug testing: the expanding role of mass spectrometry
CLH Snozek, LJ Langman, SW Cotten
LC-MS in Drug Analysis: Methods and Protocols, 1-10, 2019
102019
Multiple positive sweat chloride tests in an infant asymptomatic for cystic fibrosis
MS Willis
Labmedicine 43 (2), 1, 2012
102012
Evaluation of exocrine pancreatic function
SW Cotten
Contemporary Practice in Clinical Chemistry, 573-585, 2020
92020
The system can't perform the operation now. Try again later.
Articles 1–20